The debate over PhilHealth benefits intensifies as officials argue for increased coverage for paying members while critics warn of exclusion.
Employees contribute between P30,000 and P60,000 annually, and the system's annual fund is around P300 billion, with 10 million members receiving support of roughly P30,000 each.
The argument centers on whether contributions should translate into higher benefits for direct payers versus indirect contributors, who receive free coverage but contribute through taxes and sin levies.
Critics claim that diverting PhilHealth funds to other projects undermines universal health coverage and that the government must meet its fiscal obligations under the health act.
Supporters of the proposal argue that workers who pay significant premiums deserve enhanced protection against catastrophic illnesses such as cancer, dialysis, and heart disease.
Data shows that out‑of‑pocket health spending has risen from 2.7% to 3.3% of household consumption between 2014 and 2025, driven by increased costs of noncommunicable diseases, which now account for 50% of total health expenditure.
The share of spending on infectious diseases has fallen from 24% to 12% in the same period, reflecting changing disease patterns.
PhilHealth revenue derives largely from sin taxes on tobacco, alcohol, vaping, and gambling, which many argue should be considered indirect contributions from the population.
The Treasury returned P60 billion of excess PhilHealth funds that had been remitted back in 2024, countering allegations of misappropriation.
Proponents maintain that differentiating benefits between direct and indirect contributors is a form of service segmentation rather than exclusion, and that the state can still provide limited coverage to those who pay nothing through other public hospitals.
The debate underscores the broader challenge of balancing fiscal sustainability with equitable access to health services in a system that relies on multiple funding streams and a mix of public and private providers.
